174 related articles for article (PubMed ID: 27910077)
1. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
Kardiol Pol; 2016; 74(11):1234-1318. PubMed ID: 27910077
[No Abstract] [Full Text] [Related]
2. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; Cooney MT;
Eur Heart J; 2016 Oct; 37(39):2999-3058. PubMed ID: 27567407
[No Abstract] [Full Text] [Related]
3. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D;
Eur Heart J; 2011 Jul; 32(14):1769-818. PubMed ID: 21712404
[TBL] [Abstract][Full Text] [Related]
4. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
Reiner Z
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
[No Abstract] [Full Text] [Related]
5. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
[No Abstract] [Full Text] [Related]
6. 'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias.
Eur Heart J; 2016 Oct; 37(39):2966. PubMed ID: 27923853
[No Abstract] [Full Text] [Related]
7. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
[No Abstract] [Full Text] [Related]
8. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].
Catapano AL; Averna M; Faggiano P; Novo S
G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730
[No Abstract] [Full Text] [Related]
9. The new joint EAS/ESC guidelines for the management of dyslipidaemias.
Catapano AL; Chapman J; Wiklund O; Taskinen MR
Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901
[No Abstract] [Full Text] [Related]
10. Can the ESC/EAS LDL-cholesterol target in patients with diabetes and high cardiovascular risk be achieved in clinical practice? Results from an ambulatory multidisciplinary diabetes center cohort.
Vidal-Trécan T; Laloi-Michelin M; Bouché C; Juddoo V; Dillinger JG; Azancot I; Kevorkian JP; Salle L; Feron F; Henry P; Gautier JF; Riveline J
Diabetes Metab; 2019 Dec; 45(6):592-595. PubMed ID: 29609948
[No Abstract] [Full Text] [Related]
11. [A perspective to lipid lowering therapy after ESC/EAS guidelines for the management of dyslipidaemias and the European guidelines on cardiovascular disease prevention in clinical practice].
Ural D
Turk Kardiyol Dern Ars; 2012 Jun; 40(4):293-7. PubMed ID: 22951844
[No Abstract] [Full Text] [Related]
12. [New european guidelines for dyslipidemia].
Riesen WF; Virgini V; Vogt B; Rodondi N
Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences between European and United States guidelines for the management of dyslipidaemias.
Reiner Ž
Kardiol Pol; 2015; 73(7):471-7. PubMed ID: 26189467
[No Abstract] [Full Text] [Related]
14. Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future.
Catapano AL; Ray KK; Tokgözoglu L
Atherosclerosis; 2022 Jan; 340():51-52. PubMed ID: 34863532
[No Abstract] [Full Text] [Related]
15. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540
[No Abstract] [Full Text] [Related]
16. A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?
Dykun I; Mahabadi AA; Rassaf T
Eur Heart J; 2020 Jun; 41(24):2331. PubMed ID: 32031601
[No Abstract] [Full Text] [Related]
17. [ESC/EAS Guidelines for the management of dyslipidaemias].
Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs RH; Kjekshus JK; Perrone Filardi P; Riccardi G; Storey RF; David W;
Rev Esp Cardiol; 2011 Dec; 64(12):1168.e1-1168.e60. PubMed ID: 22115524
[No Abstract] [Full Text] [Related]
18. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: What is new?].
Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2017 Mar; 45(2):109-112. PubMed ID: 28424431
[No Abstract] [Full Text] [Related]
19. A commentary on the new ESC guidelines on dyslipidaemias.
Drexel H
Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):73-74. PubMed ID: 28363207
[No Abstract] [Full Text] [Related]
20. Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic.
Barkas F; Liberopoulos EN; Kostapanos MS; Liamis G; Tziallas D; Elisaf M
Angiology; 2015 Apr; 66(4):346-53. PubMed ID: 24830420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
